SCHEMBL23127992

SCHEMBL23127992

Nc1nccnc1NCc1ccc2ncccc2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.51
KDM4E B2RXH2 1/20 0.47
ALDH1A1 P00352 1/20 0.47
TP53 P04637 1/20 0.47
HSP90AA1 P07900 1/20 0.47
HSP90AB1 P08238 1/20 0.47
MAPT P10636 1/20 0.47
TSHR P16473 1/20 0.47
CASP1 P29466 1/20 0.47
HTT P42858 1/20 0.47
ATM Q13315 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
HSD17B10 Q99714 1/20 0.47
KDR P35968 4/20 0.46
HDAC6 Q9UBN7 1/20 0.45
HDAC3 O15379 1/20 0.45
HSPA5 P11021 1/20 0.45
HSPA8 P11142 1/20 0.45
KLKB1 P03952 2/20 0.44
KLK1 P06870 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1163132 0.84 NPC1 (0.53) NPC1KDM4EALDH1A1TP53HSP90AA1
SCHEMBL23128075 0.83 NPC1 (0.51) NPC1ALDH1A1KDRHDAC6FLT1
SCHEMBL12939261 0.83 NPC1 (0.46) NPC1KDM4EALDH1A1TP53HSP90AA1
SCHEMBL21167740 0.81 NPC1 (0.49) NPC1KDM4EALDH1A1TP53HSP90AA1
SCHEMBL21167462 0.79 KDR (0.42) NPC1ALDH1A1KDRHDAC6HDAC3
SCHEMBL24591086 0.79 NPC1 (0.47) NPC1KDM4EALDH1A1TP53HSP90AA1
SCHEMBL1330149 0.79 NPC1 (0.47) NPC1KDM4EALDH1A1TP53HSP90AA1
SCHEMBL21167816 0.79 NPC1 (0.42) NPC1KDM4EALDH1A1TP53HSP90AA1
SCHEMBL3395746 0.78 MET (0.48) NPC1KDM4EALDH1A1TP53HSP90AA1
SCHEMBL21167629 0.78 NPC1 (0.44) NPC1KDM4EALDH1A1TP53HSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3893872-B1 ORGANOPHOSPHORUS-SUBSTITUTED COMPOUNDS AS C-MET INHIBITORS AND THERAPEUTIC USES THEREOF BETA PHARMA INC (US) 2024-07-17 EP disclosed
EP-3795573-A1 CERTAIN TRIAZOLOPYRIDINES AND TRIAZOLOPYRIDINES, COMPOSITIONS THEREOF AND METHODS OF USE THEREFOR Hutchison Medipharma Limited (CN) 2021-03-24 EP disclosed